These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29588074)
1. Use of French healthcare insurance databases in pediatric pharmacoepidemiology. Kaguelidou F; Sommet A; Lapeyre-Mestre M Therapie; 2018 Apr; 73(2):127-133. PubMed ID: 29588074 [TBL] [Abstract][Full Text] [Related]
2. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies. Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637 [TBL] [Abstract][Full Text] [Related]
3. Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives. Revet A; Moulis G; Raynaud JP; Bui E; Lapeyre-Mestre M Fundam Clin Pharmacol; 2022 Feb; 36(1):16-34. PubMed ID: 33998708 [TBL] [Abstract][Full Text] [Related]
4. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284 [TBL] [Abstract][Full Text] [Related]
5. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Latry P; Molimard M; Bégaud B; Martin-Latry K Eur J Clin Pharmacol; 2010 Jul; 66(7):743-8. PubMed ID: 20429000 [TBL] [Abstract][Full Text] [Related]
6. [Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice]. de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A; Therapie; 2023; 78(6):691-703. PubMed ID: 36841652 [TBL] [Abstract][Full Text] [Related]
7. [Technical improvement of cohort constitution in administrative health databases: Providing a tool for integration and standardization of data applicable in the French National Health Insurance Database (SNIIRAM)]. Ferdynus C; Huiart L Rev Epidemiol Sante Publique; 2016 Sep; 64(4):263-9. PubMed ID: 27592033 [TBL] [Abstract][Full Text] [Related]
8. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology. Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175 [TBL] [Abstract][Full Text] [Related]
9. Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice. de Germay S; Conte C; Micallef J; Bouquet E; Chouchana L; Lafaurie M; Pariente A; Therapie; 2023; 78(6):679-689. PubMed ID: 36841656 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiological description of long-term oral glucocorticoid use: Results from the French health insurance database]. Couvaras L; Trijau S; Delamotte G; Pradel V; Pham T; Lafforgue P Rev Med Interne; 2018 Oct; 39(10):777-781. PubMed ID: 29801710 [TBL] [Abstract][Full Text] [Related]
11. Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people. Braunstein D; Donnet A; Pradel V; Sciortino V; Allaria-Lapierre V; Lantéri-Minet M; Micallef J Cephalalgia; 2015 Nov; 35(13):1172-80. PubMed ID: 25667299 [TBL] [Abstract][Full Text] [Related]
12. Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases. Berdaï D; Thomas-Delecourt F; Szwarcensztein K; d'Andon A; Collignon C; Comet D; Déal C; Dervaux B; Gaudin AF; Lamarque-Garnier V; Lechat P; Marque S; Maugendre P; Méchin H; Moore N; Nachbaur G; Robain M; Roussel C; Tanti A; Thiessard F Therapie; 2018 Feb; 73(1):13-24. PubMed ID: 29530314 [TBL] [Abstract][Full Text] [Related]
13. [Terminology used in publications of pharmacoepidemiological research in france using health insurance reimbursement databases: need for harmonisation]. Martin-Latry K; Cougnard A Therapie; 2010; 65(4):379-85. PubMed ID: 20854762 [TBL] [Abstract][Full Text] [Related]
14. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution. Dupui M; Micallef J; Lapeyre-Mestre M Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951 [TBL] [Abstract][Full Text] [Related]
15. Databases for pediatric medicine research in Europe--assessment and critical appraisal. Neubert A; Sturkenboom MC; Murray ML; Verhamme KM; Nicolosi A; Giaquinto C; Ceci A; Wong IC; Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461 [TBL] [Abstract][Full Text] [Related]
16. Current needs in pediatric pharmacoepidemiology. Lasky T; Artaman A; Czaja AS; Maruti SS; Osokogu OU; Verhamme KM; Sobel RE Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):738-42. PubMed ID: 26910571 [TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiological research using French reimbursement databases: yes we can! Martin-Latry K; Bégaud B Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):256-65. PubMed ID: 20128015 [TBL] [Abstract][Full Text] [Related]
18. [Is it possible to do pharmaco-epidemiological research using electronic databanks in the Swiss health care system?]. Meier ChR Praxis (Bern 1994); 2003 May; 92(21):997-1000. PubMed ID: 12806695 [No Abstract] [Full Text] [Related]
19. Pharmacoepidemiology. Moore N; Blin P; Droz C Handb Exp Pharmacol; 2019; 260():433-451. PubMed ID: 31768750 [TBL] [Abstract][Full Text] [Related]